Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
AaCa D3 1.25g/200unit chewable tablets sugar free
0906040G0EZABFN
|
AaCa D3 | Colecalciferol | Nutrition and Blood | 103 |
|
AaCa D3 750mg/200unit caplets
0906040G0EZAACD
|
AaCa D3 | Colecalciferol | Nutrition and Blood | 14 |
|
AaCa D3 1.25g/200unit chewable tablets
0906040G0EZADBU
|
AaCa D3 | Colecalciferol | Nutrition and Blood | No data available |
|
AaCa D3 1.5g/400unit effervescent tablets
0906040G0EZAECB
|
AaCa D3 | Colecalciferol | Nutrition and Blood | No data available |
|
AaCa D3 1.5g/400unit effervescent tablets sugar free
0906040G0EZACFP
|
AaCa D3 | Colecalciferol | Nutrition and Blood | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.